NAD+ injection vs IV vs nasal spray: how each is priced

02What telehealth sellers actually publish

The count above is every NAD+ price on file, by form and unit. Telehealth sellers ship injections and sprays to a home. An infusion is a clinic service, so it has no row here.

03Why an IV session is priced by the visit

An infusion takes hours. In one pilot study, 8 men received 750 mg of NAD+ over six hours^[1]. The authors describe that dose as a common clinic regimen^[1].

Plasma NAD+ did not rise for at least the first two hours of that infusion^[1]. The study measured blood and urine. It did not measure tissue levels or any health outcome.

So a session price pays for chair time and staff as well as the drug. To compare it with a kit, ask the clinic how many milligrams one session infuses. Then divide the session price by that number.

04The one figure that compares all three

Cost per milligram is price divided by the milligrams the unit holds. It needs one fact from the seller: the quantity. A vial label, a bottle strength or a session dose all work.

• –Injection kit: price ÷ (mg per vial × vials in the kit).
• –Nasal spray: price ÷ (mg per spray × sprays per bottle).
• –IV session: price ÷ mg infused in the session.

Where a seller states no quantity, this site prints no per-milligram figure. It shows the seller's own unit instead.

05Can it be prescribed, and what is it based on?

NAD+ is on the FDA's 503A Category 1 list^[2]. Pharmacies may compound those substances under an interim policy^[2]. Compounded NAD+ is not FDA-approved^[3].

The human evidence is thin and mostly about blood levels. One crossover trial randomized 30 healthy middle-aged and older adults^[4]. A precursor, nicotinamide riboside, raised NAD+ in their blood cells by about 60% over six weeks^[4]. That was an oral precursor, not NAD+ itself, and not an injection.